⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

CNC

Centene Corporation

Healthcare · Healthcare Plans

70.17USD

-1.0700 (-1.50%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on CNC.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$0.1▲$0.0501
Next quarter-$1.09▼-$0.9801
Current year$4.88▲$3.5200
Next year$5.35▲$4.4811

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$1.08$2.51+1.43 (+132.6%)
2026-03-31$2.13$3.37+1.24 (+57.9%)
2025-12-31-$1.22-$1.19+0.03 (+2.5%)
2025-09-30-$0.16$0.5+0.66 (+404.3%)

Wall Street coverage

396 ratings from 40 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
Argus ResearchUpgraded from HoldBuy$80Aug 11, 2026
JP MorganMaintainedNeutral$60 $67Aug 4, 2026
BernsteinMaintainedOutperform$68 $79Aug 3, 2026
BarclaysMaintainedOverweight$75 $80Jul 29, 2026
BairdMaintainedNeutral$46 $66Jul 29, 2026
TD CowenMaintainedHold$47 $65Jul 14, 2026
Truist SecuritiesMaintainedBuy$71 $78Jul 14, 2026
Wells FargoMaintainedEqual-Weight$56 $69Jul 13, 2026
RBC CapitalMaintainedSector Perform$70 $71Jul 9, 2026
Cantor FitzgeraldMaintainedOverweight$60 $75Jul 7, 2026
RBC CapitalInitiatedSector Perform$70Jun 23, 2026
MizuhoMaintainedNeutral$58 $63Jun 8, 2026
JP MorganMaintainedNeutral$52 $60Jun 8, 2026
B of A SecuritiesMaintainedBuy$72 $74Jun 4, 2026
Morgan StanleyMaintainedEqual-Weight$50 $57Jun 4, 2026
Truist SecuritiesMaintainedBuy$58 $71Jun 1, 2026
BarclaysMaintainedOverweight$63 $75May 26, 2026
UBSMaintainedNeutral$55 $61May 22, 2026
B of A SecuritiesMaintainedBuy$60 $72May 21, 2026
MizuhoMaintainedNeutral$50 $58May 20, 2026
Deutsche BankUpgraded from HoldBuy$53 $80May 20, 2026
TD CowenMaintainedHold$38 $47May 4, 2026
Wells FargoMaintainedEqual-Weight$44 $56May 1, 2026
UBSMaintainedNeutral$42 $55Apr 29, 2026
OppenheimerMaintainedOutperform$45 $58Apr 29, 2026

Insider transactions

96 filings from 23 insiders · 20 buy / 3 sell over 6m

Officers and directors of CNC, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Carson Michael AOfficer, Group President, Medicare&SpecTax7.1k$70.16$500kOct 15, 2026
Tyler Lauren MDirectorGrant482——Sep 30, 2026
TANJI KENNETHDirectorGrant603——Sep 30, 2026
Samuels Theodore R. IIDirectorGrant583——Sep 30, 2026
EPPINGER FREDERICK HDirectorGrant864——Sep 30, 2026
COUGHLIN CHRISTOPHER JDirectorGrant583——Sep 30, 2026
PIENKOS THEODORE JOfficer, Corporate Controller & CAOTax1.1k$69.41$76kSep 15, 2026
KOSTER CHRISTOPHER A.General CounselSell56.5k$66.90$3.78MAug 26, 2026
KOSTER CHRISTOPHER A.General CounselSell47.6k$65.36$3.11MAug 18, 2026
DIAZ PAUL JDirectorGrant2.8k——Jul 28, 2026
TYLER LAUREN M.DirectorGrant3.2k——Jul 17, 2026
COUGHLIN CHRISTOPHER JDirectorGrant562——Jun 30, 2026
TYLER LAUREN M.DirectorGrant61——Jun 30, 2026
EPPINGER FREDERICK HDirectorGrant833——Jun 30, 2026
SAMUELS THEODORE R IIDirectorGrant465——Jun 30, 2026
TANJI KENNETH Y.DirectorGrant581——Jun 30, 2026
BURDICK KENNETH ADirectorSell80.0k$64.55$5.16MJun 10, 2026
DALLAS HIRAM JAMESDirectorGrant4.0k——May 12, 2026
BURDICK KENNETH ADirectorGrant4.0k——May 12, 2026
BLUME JESSICA LDirectorGrant4.0k——May 12, 2026

Analyst Notes

Sign in to write

No analyst notes on CNC yet.

Top voices on CNC

Members whose judged calls on CNC have played out most reliably.

No settled calls on CNC yet. Nobody has filed a call with a deadline on it.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice

Analyst Ratings

18 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current171210Hold2.62
1 mo ago171210Hold2.62
2 mo ago171210Hold2.62
3 mo ago161310Hold2.67
Price target$71.78$56.00 – $85.00
+2.3% to target